Internal Medicine, Hematology & Oncology · Manati, PR
NPI
1124288618
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Mmc Professional Plaza, Suite 103
Manati, PR, 00674
Phone (787) 884-7202
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,776
639 services
Medicare patients, 2024
22
Average age 72
Drug cost, 2024
$8.1M
1,996 prescriptions
Company payments, 2025
$2,174
From 22 companies
Medicare prescription drug claims, 2024
In 2024, the drug Dania L Santiago-Caraballo prescribed most often to Medicare patients was Anastrozole, with 305 prescriptions and refills. In total Dania L Santiago-Caraballo wrote 1,996 Medicare prescriptions that cost $8.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 305 | 393 | 68 | $4,927 |
| Hydroxyurea Generic | 122 | 130 | 22 | $3,023 |
| Prednisone Generic | 103 | 103 | 24 | $896 |
| Revlimid Lenalidomide | 102 | 102 | 16 | $1.7M |
| Eliquis Apixaban | 82 | 89 | 25 | $53K |
| Synthroid Levothyroxine Sodium | 78 | 82 | 20 | $4,040 |
| Warfarin Sodium Generic | 76 | 78 | 11 | $571 |
| Dexamethasone Generic | 62 | 62 | 25 | $1,014 |
| Abiraterone Acetate Generic | 58 | 58 | 11 | $94K |
| Xarelto Rivaroxaban | 53 | 53 | Under 11 | $28K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 48 | 48 | 29 | $474 |
| Xtandi Enzalutamide | 47 | 47 | Under 11 | $632K |
| Letrozole Generic | 36 | 44 | Under 11 | $495 |
| Jakafi Ruxolitinib Phosphate | 36 | 36 | Under 11 | $623K |
| Exemestane Generic | 34 | 34 | Under 11 | $2,091 |
Brand drugs: 787 claims; generic drugs: 1,209 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dania L Santiago-Caraballo $2,174 ($2,174 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $303.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $303 |
| Merck Sharp & Dohme LLC MRK | 9 | $209 |
| Janssen Pharmaceuticals, Inc JNJ | 7 | $186 |
| Incyte Corporation INCY | 5 | $167 |
| Abbvie Inc. ABBV | 7 | $166 |
| GlaxoSmithKline, LLC. GSK | 4 | $160 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $150 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $121 |
| Tempus AI, Inc TEM | 4 | $88.57 |
| Caris MPI, Inc. | 3 | $85.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.